The eŠects of dietary eritadenine on the concentration of plasma lipoprotein lipids and the molecular species proˆle of plasma lipoprotein phosphatidylcholine (PC) were investigated in rats fed cholesterol-free and cholesterol-enriched diets to obtain insights into the relationship between the changes in PC molecular species proˆle and the hypocholesterolemic action of eritadenine. The eŠect of eritadenine on the secretion rate of very low density lipoprotein (VLDL) from the liver was also estimated. Rats were fed the control or eritadenine-supplemented (50 mg W kg) diets with or without exogenous cholesterol for 14 d. Eritadenine supplementation signiˆcantly decreased the cholesterol of major plasma lipoproteins, high density lipoprotein and VLDL, in rats fed cholesterol-free and cholesterolenriched diets, respectively. The ratio of PC to phosphatidylethanolamine, D6-desaturase activity, and the ratio of arachidonic acid to linoleic acid in liver microsomes were markedly decreased by eritadenine irrespective of the presence or absence of exogenous cholesterol. Dietary eritadenine increased the proportion of 16:0-18:2 molecular species with a decrease in 18:0-20:4 in plasma lipoprotein PC in both rats fed cholesterolfree and cholesterol-enriched diets. Eritadenine did not depress the secretion rate of VLDL in rats fed a cholesterol-free diet containing a high level of choline. The results indicate that dietary eritadenine elicits its hypocholesterolemic action with modulations of the fatty acid and molecular species proˆles of PC irrespective of the presence or absence of exogenous cholesterol. The eritadenine-induced alteration of PC molcular species proˆle is discussed in relation to the hypocholesterolemic action of eritadenine.
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The mushroom Lentinus edodes (Shiitake in Japanese) has a hypocholesterolemic eŠect in rats, 1) and the eŠect is mainly attributable to a compound, eritadenine [2(R),3(R)-4-(9-adenyl)-butyric acid]. 2, 3) Earlier studies suggested that eritadenine might exert its hypocholesterolemic action through either increased upatake of plasma lipoprotein cholesterol by tissues, decreased secretion of plasma lipoprotein cholesterol from the liver, or both. 4, 5) In addtion to the hypocholesterolemic action, eritadenine or L. edodes has been shown to alter several variables concerning lipid metabolism, e.g., a decrease in the phosphatidylcholine (PC) W phosphatidylethanolamine (PE) ratio of liver microsomes, [6] [7] [8] a decrease in the 20:4n-6 W 18:2n-6 ratio of phospholipids and cholesteryl esters, 9, 10) and a decrease in liver microsomal D6-desaturase activity 11) in rats. The molecular species proˆle of liver microsomal and plasma PC was also markedly in‰uenced by eritadenine. [9] [10] [11] These changes induced by eritadenine are considered to be associated, in some way and to some extent, with the hypocholesterolemic action, but conclusive results have not yet been obtained. One of the characteristics of the hypocholesterolemic eŠect of eritadenine or L. edodes is that the compound or the mushroom signiˆcantly decreased the plasma cholesterol concentration in both rats fed cholesterolfree 4) and cholesterol-enriched 1, 4) diets. It is conˆrmed that plasma lipoprotein proˆles are largely in‰uenced by the presence or absence of exogenous cholesterol in rats. Unlike human plasma in which low density lipoprotein (LDL) is a major lipoprotein, high density lipoprotein (HDL) and very low density lipoprotein (VLDL) are the major lipoproteins in rats fed cholesterol-free and cholesterol-enriched diets, respectively. Although the eŠects of eritadenine on the phospholipid and fatty acid metabolism have been studied with rats fed a cholesterol-free diet, [7] [8] [9] [10] [11] little information is available whether eritadenine also markedly aŠects the metabolism of phospholipids and fatty acids even in rats fed a cholesterol-enriched diet. Furthermore, it is still unclear whether eritadenine aŠects lipid proˆles of each plasma lipopoprotein (VLDL, LDL, and HDL) in a similar or diŠerent manner. On the other hand, previously we demonstrated that eritadenine-induced fatty liver could be eŠectively prevented when an adequate amount of choline was included in the diet to compensate for depressed PC synthesis via the PE N-methylation pathway, 8) suggesting that the hypocholesterolemic eŠect of eritadenine must be assessed under the condition of adequate dietary choline. This raises a question whether eritadenine actually depresses the secretion of lipoprotein cholesterol from the liver, since attention was not fully given to the dietary choline level in earlier studies.
In this study, we investigated the eŠects of dietary eritadenine on the concentration of plasma lipoprotein lipids and the molecular species proˆle of plasma lipoprotein PC with rats fed cholesterol-free and cholesterol-enriched diets. Additionally, the eŠect of eritadenine on the secretion rate of VLDL from the liver was also estimated using rats fed a diet containing a high level of choline.
Materials and Methods
Chemicals. Eritadenine was kindly provided from Tanabe Seiyaku (Osaka). [1- 14 C]Linoleic acid (1.7 GBq W mmol) was purchased from New England Nuclear (Boston, MA, USA). Phospholipase C was purchased from Boehringer Mannheim (Mannheim, Germany). Unlabeled linoleic acid and other biochemicals were purchased from Wako Pure Chemical (Osaka) or Sigma (St. Louis, MO, USA). All other chemicals were purchased from Wako and were of analytical grade. Mineral and vitamin mixtures (AIN-76) were purchased from Oriental Yeast (Tokyo) and other ingredients of diet were from Wako or Nacalai Tesque (Kyoto).
Animals and diets. Forty male 6-wk-old rats of the Wistar strain were received at 120-130 g body weight from Japan SLC (Hamamatsu). The rats were individually housed in hanging stainless-steel wire cages kept in an isolated room at a controlled temperature (23-259 C) and humidity (40-60z) . Light were maintained on a 12-h cycle (lights on from 0600 to 1800 h). For 4 or 5 d, rats were fed the powdered laboratory stock diet as described previously. 10) Then, they were divided into four groups of ten rats each with similar mean body weights (150 g) and allowed free access to the experimental diets and water for 14 d. Four diets with or without cholesterol and eritadenine were used in this study. The composition of the cholesterol-free control diet was as follows ( Tissue collection and fractionation. At the end of the feeding period, rats were killed by decapitation under light anesthesia with diethyl ether between 1200 and 1230 with prior 5 h without food. Plasma was separated from heparinized whole blood by centrifugation at 2000×g for 20 min at 49 C. A sample of plasma was put through density gradient ultracentrifugation to separate plasma lipoproteins into three fractions (VLDL, LDL, and HDL) as described by Terpstra et al. 12, 13) with slight modiˆcations. In brief, 1.8 ml of pooled plasma from two rats each was centrifuged by a ultracentrifuge (Model CP-56G; Hitachi, Tokyo, Japan) at 200,000×g for 19 h at 109 C. Under these conditions, three fractions were clearly separated when plasma lipids were stained with Sudan black. The fractions with density º1.006, 1.006-1.063, and 1.063-1.210 were assumed to be VLDL, LDL, and HDL, respectively. A small portion of each lipoprotein fraction was stored at -309 C until subsequent analyses for lipids and apoproteins, and the residual lipoprotein fraction was stored at -309 C until analysis for the molecular species composition of PC. After collection of blood, the whole liver was quickly removed, rinsed in icecold saline, blotted onˆlter paper, and weighed. The liver was homogenized in 4 vol (vol W wt) of an ice-cold 10 mM Tris-HCl buŠer (pH 7.4) containing 0.25 M sucrose. A portion (2 ml) of the homogenate was stored at -309 C until subsequent analyses for liver lipid concentrations. Another portion (12 ml) of the homogenate was centrifuged at 10,000×g for 12 min at 49 C, and the resultant supernatants were further centrifuged at 105,000×g for 60 min at 49 C to obtain the microsomal fraction as a precipitate. The microsomes obtained were resuspended in the homogenizing buŠer and stored at -309 C until analyses for the molecular species composition of PC and 1,2-diacylglycerols.
Lipid analysis. The total cholesterol, triglycerides, and phospholipids in each lipoprotein fraction were measured enzymatically with kits (Cholesterol CTest, Triglyceride G-Test, and Phospholipid B-Test, respectively; Wako). The total lipids of liver homogenate, liver microsomes, and each plasma lipoprotein fraction were extracted by the method of Folch et al.
14) The cholesterol, triglycerides, and phospholipids in the extract of liver homogenate were measured by the methods of Zak, 15) Fletcher, 16) and Bartlett, 17) respectively. For the analysis of phospholipid class composition, the phospholipids in the extract of liver microsomes were separated into each class by thin-layer chromatography (TLC) on silica gel 60 (E. Merck, Darmstadt, Germany) using chloroform W methanol W water (65:25:4, by vol) as a developing solvent. The bands of each phospholipid class were stained in iodine vapor, scraped oŠ the plate, and analyzed directly for inorganic phosphorus. 17) For the analysis of molecular species composition, PC was likewise separated by TLC from the extracts of liver microsomes and each plasma lipoprotein fraction, stained with dichloro‰uores-cein, scraped oŠ the plate, and extracted with chloroform W methanol (1:2, by vol). A portion of the PC was converted to diacylglycerol benzoates by the method of Blank et al.
18) The diacylglycerol benzoates were analyzed by high-pressure liquid chromatography (HPLC) on a Model LC-10A system (Shimadzu, Kyoto), equipped with an ODS column (4.6×250 mm, Lichrosorb RP-18; E. Merck), essentially according to the method of Blank et al. 18) Since some peaks consisted of two or three peaks, samples were rechromatographed using diŠerent elution solvents. 19) 1,2-Diacylglycerols were separated from the extract of liver microsomes by TLC on a silica gel 60 using hexane W diethyl ether W acetic acid (80:20:1, by vol), stained with dichloro‰uorescein, scraped oŠ the plate, and extracted with chloroform W methanol (1:2, by vol). Thus obtained 1,2-diacylglycerols were directly converted to benzoyl derivatives, without phospholipase C treatment, and analyzed by HPLC as described above.
Enzyme assay. The activity of D6-desaturase in liver microsomes was measured essentially by the method of Svensson, 20) with slight modiˆcations. In brief, the reaction mixture (total 1.5 ml) consisted of 75 mM phosphate buŠer (pH 7.0), 0.15 M KCl, 0.25 M sucrose, 0.5 mM nicotinamide, 5.5 mM MgCl2, 5 mM ATP, 1.5 mM glutathione, 0.5 mM CoA, 1 mM NADH, 133 mM [1-
14 C]linoleic acid (28 MBq W mmol), and liver microsomes (ca. 3 mg). After incubation without NADH for 10 min at 379 C, the reaction was started by adding NADH, and the reaction mixture was further incubated for 20 min at 379 C in a test tube of wide bore (16 mm) with reciprocal shaking (120 cycle W min). The reaction was stopped by adding 1 ml of methanol containing 10z KOH (weight W volume). After saponiˆcation and subsequent acidiˆ-cation, fatty acids were extracted with petroleum ether. The extracted fatty acids, together with carrier fatty acids (linoleic acid and g-linolenic acid), were methylated with BF3 W methanol reagent. The fatty acid methyl esters were separated by HPLC with an ODS column (4.6×250 mm, YMC-Pack ODS-A; YMC, Kyoto). The mobile phase was acetonitrile W water (97:3, by volume). The ‰ow rate was 1 ml W min, and the elution was monitored at 195 nm. The eOEuents of peaks of substrate and product were collected, and the radioactivity was counted by a liquid scintillation counter (Model LSC-6100; Aloka, Tokyo).
Secretion rate of very low density lipoprotein lipids. The secretion rate of very low density lipoprotein lipids from the liver was estimated essentially by the method of Venkatesan et al. 21) Twentyfour rats were divided into two groups (12 rats each) and fed cholesterol-free control or eritadenine supplemented diets as described above, but containing a higher amount of choline (0.8z choline chloride), for 14 days. On the 14th day, six rats of each group were injected via the tail vein either with saline or Triton WR-1339 solution (200 mg W ml) at a level of 600 mg W kg of body weight between 1200 and 1230 h after going without food for 5 h, and then the rats were killed just 2 h after the injection of Triton WR-1339 to obtain blood and liver. The VLDL fraction was separated by ultracentrifugation, and triglycerides and cholesterol of VLDL were measured with kits as described above. The secretion rate of VLDL lipids was calculated by the method of Venkatesan et al. 21) and expressed as mmol W h W g of liver.
Protein assay. Plasma apoproteins and liver microsomal proteins were measured by the method of Lowry et al. 22) using bovine serum albumin as a standard.
Statistical analysis. Data were expressed as mean± SEM. Data were analyzed by two-way analysis of variance (ANOVA), and the diŠerences between means were tested using Duncan's multiple range test 23) when the F value was signiˆcant. Student's ttest was used to examine the signiˆcance between the two experimental groups. A simple correlation between two variables was calculated by linear regression analysis using the mean values. A p value of 0.05 or less was considered signiˆcant.
Results
Growth, food intake, liver weight, liver lipids, and D6-desaturase activity Neither dietary eritadenine nor cholesterol aŠected the body weight gain and food intake of animals (Table 1) . Relative liver weights were signiˆcantly higher in rats fed a cholesterol-enriched diet than in rats fed a cholesterol-free diet. Hepatic cholesterol and triglyceride concentrations were signiˆcantly aŠected only by dietary cholesterol, whereas hepatic phospholipid concentration tended to be increased by eritadenine supplementation. The concentration of PC in liver microsomes was not diŠerent among the four groups, but the concentration of PE was signiˆcantly increased by eritadenine. The PC W PE ratio of liver microsomes was signiˆcantly in‰uenced by both dietary eritadenine and cholesterol, although the eŠect of eritadenine was greater than that of cholesterol and there was no additive eŠect of eritadenine and cholesterol. The concentrations of the other phospholipid classes were less in‰uenced by dietary eritadenine and cholesterol. The increase in PE concentration was re‰ected in the increase in microsomal total phospholipids. The cholesterol concentration in liver microsomes was signiˆcantly increased by dietary cholesterol both when expressed as per protein and per PC. The microsomal D6-desaturase activity signiˆcantly decreased in response to dietary eritadenine and cholesterol, but there was no additive eŠect of eritadenine and cholesterol.
Plasma lipoprotein lipid concentrations
The concentrations of plasma lipoprotein lipids, except for triglycerides, and apoproteins were signiˆcantly in‰uenced by both dietary eritadenine and cholesterol (Table 2) . In rats fed a cholesterol-free diet, the concentration of plasma cholesterol associated with HDL and LDL, but not VLDL, was signiˆcantly decreased by eritadenine. In rats fed a cholesterol-enriched diet, the concentration of cholesterol associated with all the lipoproteins was signiˆcantly decreased by eritadenine, although the change in VLDL was greater than that in HDL or LDL. The plasma triglyceride concentration of each lipoprotein was least aŠected by dietary eritadenine and cholesterol. The concentrations of phospholipids and apoproteins of plasma lipoproteins were aŠected by dietary eritadenine and cholesterol in a similar manner to that of plasma lipoprotein cholesterol. Tables 3 and 4 show the molecular species composition of liver microsomal and plasma lipoprotein PC. Dietary eritadenine and cholesterol aŠected, more or less, the proportion of most of the PC molecular species in liver microsomes. Of major molecular species, the proportion of 16:0-18:2 and 18:0-18:2 was increased and inversely the proportion Table 2 for abbreviations of statistical analysis. of each plasma lipoprotein PC was also in‰uenced by eritadenine supplementation in a similar manner to that of liver microsomal PC; e.g., there was a signiˆcant correlation for the proportion of each PC molecular species between microsomal PC and VLDL-PC (r＝0.940, pº0.001, n＝64). Furthermore, there was no essential diŠerence in the PC molecular species proˆle among VLDL, LDL and HDL; correlation coe‹cients for the molecular species composition of PC between VLDL and LDL, LDL and HDL, and VLDL and HDL were 0.994, 0.999, and 0.994, respectively ( pº0.001, n＝64). PC, phosphatidylcholine. See Table 2 for abbreviations of statistical analysis. Table 5 shows the eŠects of dietary eritadenine on the proportion of major fatty acids in the sn-1 and sn-2 positions of PC in each plasma lipoprotein. In the sn-1 position, the proportion of 16:0 was signiˆcantly increased and inversely the proportion of 18:0 and 18:1 was signiˆcantly decreased by eritadenine supplementation irrespective of the presence or absence of dietary cholesterol. In the sn-2 position, the proportion of 18:1 and 18:2 was signiˆcantly increased and inversely the proportion of 20:4 was signiˆcantly decreased by eritadenine supplementation irrespective of the presence or absence of dietary cholesterol. In the absence of dietary eritadenine, dietary cholesterol increased the proportion of 16:0 Table 6 shows the eŠects of dietary eritadenine on the molecular species proˆle of liver microsomal diacylglycerols in rats fed a cholesterol-free diet. Although the molecular species proˆle of diacylglycerols was much diŠerent from that of microsomal PC, the proportion of some molecular species containing 18:2 such as 16:0-18:2, 18:1-18:2, and 18:2-18:2 were signiˆcantly increased by eritadenine supplementation. The proportion of some molecular species containing 20:4 such as 16:0-20:4 and 18:0-20:4 was conversely decreased by eritadenine.
Molecular species composition of phosphatidylcholine and diacylglycerols

Secretion rate of very low density lipoprotein lipids
The secretion rates of VLDL cholesterol from the liver, as measured by Triton WR-1339 injection, were 0.46±0.07 and 0.67±0.09 (mmol W h W g of liver, n＝6) in control rats and eritadenine-fed rats, respectively. The secretion rates of VLDL triglycerides were 9.2± 0.9 and 12.1±1.3 (mmol W h W g of liver, n＝6) in control rats and eritadenine-fed rats, respectively. Thus, the secretion rates of VLDL lipids from the liver tended to be slightly higher in eritadenine-fed rats than in control rats, but there was no signiˆcant diŠerence between the two groups.
Discussion
EŠects on molecular species composition of phosphatidylcholine
This study demonstrated that eritadenine could modify the molecular species composition of PC in liver microsomes and each plasma lipoprotein not only in rats fed a cholesterol-free diet but also in rats fed a cholesterol-enriched diet. Consistent with our previousˆndings, [9] [10] [11] the most prominent changes induced by eritadenine were an increase in the proportion of 16:0-18:2 PC and a decrease in the proportion of 18:0-20:4 PC irrespective of the presence or absence of exogenous cholesterol. This study also showed that the molecular species proˆles of PC were quite similar among liver microsomes, VLDL, LDL, and HDL. Thisˆnding might be explaind by the facts that the major part of plasma PC is exclusively derived from the liver 24) and phospholipid transfer protein catalyzes the transfer of PC between diŠerent lipoproteins. 25) In mammals, PC is synthesized by both the CDP-choline pathway and the PE N-methylation pathway. In rats fed a eritadenine-supplemented diet, PC is considered to be synthesized predominantly by the CDP-choline pathway, since the PE N-methylation was inhibited by more than 90z. 7) In cultured rat hepatocytes, Delong et al. 26) demonstrated that one of the roles of the PE N-methylation pathway is to provide 18:0-20:4 PC molecular species. Therefore, it is likely that the increased PC synthesis via the CDP-choline pathway with the cessation of PE N-methylation in eritadenine-fed rats might contribute to the decrease in 18:0-20:4 molecular species in PC. At thê nal step of the CDP-choline or CDP-ethanolamine pathway, CDP-choline or CDP-ethanolamine reacts with 1,2-diacylglycerols to form PC and PE, respectively, indicating that the molecular species proˆle of 1,2-diacylglycerols might be re‰ected, while not directly, in that of PC or PE. Therefore, we measured the molecular species composition of liver microsomal 1,2-diacylglycerols toˆnd whether eritadenine aŠects the molecular species proˆle at an early step of PC or PE synthesis. The results showed that eritadenine signiˆcantly increased the proportion of 16:0-18:2 molecular species and decreased the proportion of 18:0-20:4 molecular species of 1,2-diacylglycerol, although the molecular species proˆle of 1,2-diacylglycerol was, as a whole, largely diŠerent from that of PC, especially in that the proportion of molecular species containing 20:4 was markedly lower than that of PC. These results suggest that eritadenine increases the proportion of 16:0-18:2 mollecular species and decreases the proportion of arachidonic acid-containing molecular species already at a level of 1,2-diacylglycerols. Thus, it is likely that dietary eritadenine might modify PC molecular species composition through the pronounced inhibition of PE N-methylation and alter 1,2-diacylglycerol molecular species composition, possibly due to the suppression of linoleic acid metabolism. It is conˆrmed that nascent molecular species of phospholipids are modiˆed by remodelling through deacylation-reacylation. [27] [28] [29] However, it is unclear how eritadenine aŠects the PC molecular species proˆle in the course of phospholipid remodeling.
It has been suggested that the decrease in the PC W cholesterol and PC W PE ratio of liver microsomal membranes may decrease the activity of microsomal D6-desaturase activity, probably through alteration of membrane ‰uidity. [30] [31] [32] Actually, dietary supplementation with cholesterol decreased the D6-desaturase activity in a dose-dependent manner in rats 33) and there was a signiˆcant correlation between the microsomal PC W PE ratio and D6-desaturase activity in rats fed cholesterol-free diets supplemented with graded levels of eritadenine. 11) This study also supports the idea that the decrease in the PC W PE ratio and the increase in choloesterol concentration in liver microsomes may be associated with a decrease in the activity of D6-desaturase. On the other hand, it was shown that the abundance of mRNA for D6-desaturase in mice fed a diet containing 10z corn oil was 50z lower than in mice fed a diet containing triolein, 34) suggesting that dietary linoleic acid, as compared with oleic acid, may decrease the enzyme activity by transcriptional regulation. Furthermore, the decreased D6-desaturase activity observed in diabetic rats was accompanied by a reduction of the abundance of mRNA for the enzyme. 35) Thus, certain types of treatment decreased the D6-desaturase activity through suppression of gene expression of the enzyme. On the other hand, Brenner et al. demonstrated that 36) dietary supplementation with cholesterol suppressed the activity of D6-desaturase without a reduction of mRNA for the enzyme. In contrast, recently we found that dietary eritadenine-induced suppression of D6-desaturase activity was accompanied by a decrease in the mRNA (unpublished data), suggesting that unlike dietary cholesterol, eritadenine decreases D6-desaturase activity through suppression of gene expression of the enzyme. It is interesting to note that the cells of an insect (fruit ‰y) had a sterol regulatory elementbinding protein (SREBP)-mediated regulation system that was regulated by PE rather than cholesterol and fatty acids. 37) It was demonstrated that the expression of D5-and D6-desaturase was activated by SREBPs, especially SREBP-1, in mouse liver. 38) Theseˆndings, together with the PE-increasing eŠect of eritadenine, suggest a possibility that the suppressive eŠect of eritadenine on D6-desaturase activity may be mediated by the PE-mediated regulation system.
Hypocholesterolemic action of eridenine
It has been shown that eritadenine elicits its hypocholesterolemic action in both rats fed cholesterol-free and cholesterol-enriched diets. 1, 4) Earlier studies have shown that eritadenine neither inhibited cholesterogenesis in the liver 4, 39, 40) nor stimulated steroid excretion into feces. 41) On the other hand, the clearance rate of plasma cholesterol was faster in eritadenine-treated rats than in control rats. 4) Furthermore, the secretion rate of plasma lipoproteins from the liver was slightly decreased by eritadenine. 5) Thus, earlier studies suggest that eritadenine might elicit its hypocholesterolemic action either through increased uptake of plasma lipoprotein cholesterol by tissues, depressed secretion of plasma lipoprotein cholesterol from the liver, or both. It has been frequently observed that dietary supplementation with L. edodes or eritadenine resulted in development of fatty liver. This arises from PC deˆciency due to the inhibition of PC synthesis via the PE N-methylation pathway, since eritadenineinduced fatty liver could be eŠectively prevented by increasing the dietary level of choline, a precursor for PC synthesis via the CDP-choline pathway, in rats. 8) The marked hypocholesterolemic action of eritadenine could be observed even when fatty liver was prevented by a high level of dietary choline chloride (8 g W kg). 8) In this study, therefore, the secretion rate of plasma VLDL lipids from the liver was reevaluated under the same conditions. The results obtained, that the secretion rate of plasma VLDL cholesterol was not decreased in eritadenine-fed rats as compared with control rats, suggest that the essential mechanism for the hypocholesterolemic action of eritadenine cannot be ascribed to the depressed secretion of plasma lipoprotein cholesterol from the liver. Thus, the remaining possibility is that eritadenine might elicit its hypocholesterolemic action through increased uptake of plasma lipoprotein cholesterol by tissues, probably by the liver.
At least two possibilities are considered for the increased uptake of plasma lipoprotein cholesterol by the liver; (i) the increased activity of lipoprotein receptors and (ii) increased uptake of lipoprotein cholesterol due to changes in the nature of lipoproteins. It is conˆrmed that the uptake of plasma lipoprotein lipids by tissues is regulated by a receptor-mediated mechanism. 42) Although it is unclear whether eritadenine aŠects the lipoprotein receptor activity, the possibility that eritadenine aŠects the PC W PE ratio and W or molecular species proˆle of phospholipids in liver cell membranes, where receptors exist, and thereby increases the activities of lipoprotein receptors cannot be excluded. On the other hand, there are several reports to indicate that the uptake rate of plasma lipoprotein lipids was in‰uenced by the molecular species of plasma lipoprotein PC. For instance, the uptake rate of cholesteryl oleate of reconstituted HDL by perfused rat livers was most stimulated by 16:0-18:2 PC ofˆve molecular species used to reconstitute HDL particles (16:0-18:2, 16:1-16:1, 18:0-18:2, 18:1-16:0 and 20:1-20:1). 43) These results were accounted for by the critical role of hepatic lipase in the uptake of HDL cholesterol by the liver, since hepatic lipase has a phospholipase A1 activity and the highest rate of PC hydrolysis was observed with reconstituted HDL containing 16:0-18:2 PC. 43) Several reports also suggested that hepatic lipase might promote the uptake of HDL cholesterol by the liver through the hydrolysis of PC in HDL, [44] [45] [46] although recent reports have demonstrated that in addition to the lipolytic function, a nonlipolytic function of hepatic lipase is also important for HDL metabolism. 47, 48) This study demonstrated that dietary eritadenine markedly increased the proportion of plasma 16:0-18:2 PC molecular species, the most preferred substrate for hepatic lipase. Therefore, hepatic lipase-mediated stimulation of the uptake of HDL cholesterol may participate in the hypocholesterolemic action of eritadenine in rats fed a cholesterol-free diet, where HDL is the major plasma lipoprotein.
This study also demonstrated that dietary eritadenine markedly modiˆed the PC molecular species proˆle of plasma lipoproteins in rats fed a cholesterol-enriched diet, where VLDL rich in cholesterol is the major plasma lipoprotein. In rabbits, dietary cholesterol-induced cholesterol-rich VLDL is called b-VLDL and thought to consist predominantly of chylomicron remnants. 49) Hence, the VLDL fraction obtained from rats fed a cholesterol-enriched diet in this study is considered to contain chylomicron remnants in addition to VLDL and VLDL remnants. Remnants of chylomicrons and VLDL are taken up by the liver. It has been shown that hepatic lipase stimulates the hepatic uptake of chylomicron remnants 50, 51) or b-VLDL.
52) The phospholipolysis of chylomicrons by hepatic lipase, in combination with lipoprotein lipase, was demonstrated to be a necessary requirement for the generation of remnant particles that can be recognized and taken up by the liver, 53) although hepatic lipase has been proposed to play a major role in cellular lipoprotein metabolism by serving as a ligand that mediates the interaction between remnant lipoproteins and cell surface receptors and W or proteoglycans. [54] [55] [56] The fatty acid composition of chylomicrons was shown to aŠect the hepatic uptake of cholesterol of chylomicrons, 57) but it is still unclear whether PC molecular species proˆle aŠects the uptake rate of cholesterol of remnants of chylomicrons or VLDL in a manner similar to that of HDL.
